Regulatory oversight of behavioral digital therapeutics for addiction treatment: A commentary on Khadjesari et al.

Commentary
by
Vilardaga, Roger, and F. Joseph McClernon

Release Date

2021

Geography

USA

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

No

Findings/Key points

As noted by Khadjesari et al., digital therapeutics have the promise to reduce the treatment reach gap -- or at least mitigate this shortage by supplying additional means of help. However, making digital therapeutics widely available does not guarantee that they will have an equitable public health impact. For instance, the ‘digital divide’ is a new social determinant of health [3] that may increase health inequities among vulnerable patient populations

Keywords

Policy/Regulatory
Digital health